147 related articles for article (PubMed ID: 10197850)
1. Polyclonal and monoclonal antibodies to prostate-specific antigen can cross-react with human kallikrein 2 and human kallikrein 1.
Finlay JA; Day JR; Rittenhouse HG
Urology; 1999 Apr; 53(4):746-51. PubMed ID: 10197850
[TBL] [Abstract][Full Text] [Related]
2. Cross-reactivity of ten anti-prostate-specific antigen monoclonal antibodies with human glandular kallikrein.
Corey E; Buhler KR; Vessella RL
Urology; 1997 Oct; 50(4):567-71; discussion 571-2. PubMed ID: 9338733
[TBL] [Abstract][Full Text] [Related]
3. Production of recombinant PSA and HK2 and analysis of their immunologic cross-reactivity.
Lövgren J; Piironen T; Overmo C; Dowell B; Karp M; Pettersson K; Lilja H; Lundwall A
Biochem Biophys Res Commun; 1995 Aug; 213(3):888-95. PubMed ID: 7544581
[TBL] [Abstract][Full Text] [Related]
4. Development of monoclonal antibodies specific for human glandular kallikrein (hK2): development of a dual antibody immunoassay for hK2 with negligible prostate-specific antigen cross-reactivity.
Finlay JA; Evans CL; Day JR; Payne JK; Mikolajczyk SD; Millar LS; Kuus-Reichel K; Wolfert RL; Rittenhouse HG
Urology; 1998 May; 51(5):804-9. PubMed ID: 9610595
[TBL] [Abstract][Full Text] [Related]
5. Determination and analysis of antigenic epitopes of prostate specific antigen (PSA) and human glandular kallikrein 2 (hK2) using synthetic peptides and computer modeling.
Piironen T; Villoutreix BO; Becker C; Hollingsworth K; Vihinen M; Bridon D; Qiu X; Rapp J; Dowell B; Lövgren T; Pettersson K; Lilja H
Protein Sci; 1998 Feb; 7(2):259-69. PubMed ID: 9521101
[TBL] [Abstract][Full Text] [Related]
6. Immunoreactivity of recombinant human glandular kallikrein using monoclonal antibodies raised against prostate-specific antigen.
Eerola R; Piironen T; Pettersson K; Lövgren J; Vehniäinen M; Lilja H; Dowell B; Lövgren T; Karp M
Prostate; 1997 May; 31(2):84-90. PubMed ID: 9140120
[TBL] [Abstract][Full Text] [Related]
7. Development of an ultrasensitive immunoassay for human glandular kallikrein with no cross-reactivity from prostate-specific antigen.
Black MH; Magklara A; Obiezu CV; Melegos DN; Diamandis EP
Clin Chem; 1999 Jun; 45(6 Pt 1):790-9. PubMed ID: 10351987
[TBL] [Abstract][Full Text] [Related]
8. Reactivity of anti-PSA monoclonal antibodies with recombinant human kallikrein-2.
Leinonen J; Leinimaa M; Zhang WM; Piironen T; Pettersson K; Lilja H; Dowell B; Stenman UH
Tumour Biol; 1999; 20 Suppl 1():35-7. PubMed ID: 10628407
[TBL] [Abstract][Full Text] [Related]
9. Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate.
Rittenhouse HG; Finlay JA; Mikolajczyk SD; Partin AW
Crit Rev Clin Lab Sci; 1998 Aug; 35(4):275-368. PubMed ID: 9759557
[TBL] [Abstract][Full Text] [Related]
10. Immunofluorometric assay for sensitive and specific measurement of human prostatic glandular kallikrein (hK2) in serum.
Piironen T; Lövgren J; Karp M; Eerola R; Lundwall A; Dowell B; Lövgren T; Lilja H; Pettersson K
Clin Chem; 1996 Jul; 42(7):1034-41. PubMed ID: 8674186
[TBL] [Abstract][Full Text] [Related]
11. Western blotting analysis of antibodies to prostate-specific antigen: cross-reactivity with human kallikrein-2.
Wang TJ; Linton HJ; Rittenhouse HG; Wolfert RL
Tumour Biol; 1999; 20 Suppl 1():75-8. PubMed ID: 10628412
[TBL] [Abstract][Full Text] [Related]
12. Epitope analysis of a prostate-specific antigen (PSA) C-terminal-specific monoclonal antibody and new aspects for the discrepancy between equimolar and skewed PSA assays.
Nagasaki H; Watanabe M; Komatsu N; Kaneko T; Dubé JY; Kajita T; Saitoh Y; Ohta Y
Clin Chem; 1999 Apr; 45(4):486-96. PubMed ID: 10102908
[TBL] [Abstract][Full Text] [Related]
13. Time-resolved fluorescence imaging for specific and quantitative immunodetection of human kallikrein 2 and prostate-specific antigen in prostatic tissue sections.
Siivola P; Pettersson K; Piironen T; Lövgren T; Lilja H; Bjartell A
Urology; 2000 Oct; 56(4):682-8. PubMed ID: 11018639
[TBL] [Abstract][Full Text] [Related]
14. Kininogenase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid.
Charlesworth MC; Young CY; Miller VM; Tindall DJ
J Androl; 1999; 20(2):220-9. PubMed ID: 10232657
[TBL] [Abstract][Full Text] [Related]
15. Structural comparison of prostate-specific antigen and human glandular kallikrein using molecular modeling.
Bridon DP; Dowell BL
Urology; 1995 May; 45(5):801-6. PubMed ID: 7538242
[TBL] [Abstract][Full Text] [Related]
16. Characterization of monoclonal antibodies for prostate-specific antigen and development of highly sensitive free prostate-specific antigen assays.
Black MH; Grass CL; Leinonen J; Stenman UH; Diamandis EP
Clin Chem; 1999 Mar; 45(3):347-54. PubMed ID: 10053035
[TBL] [Abstract][Full Text] [Related]
17. Generation of monoclonal antibodies specific for human kallikrein 2 (hK2) using hK2-expressing tumors.
Fisher TL; Nocera M; Willis RA; Turner MJ; Abdul Alim CS; Brown DM; Bourne PA; di Sant'Agnese PA; Messing EM; Lord EM; Frelinger JG
Prostate; 2002 May; 51(3):153-65. PubMed ID: 11967950
[TBL] [Abstract][Full Text] [Related]
18. Sensitive and specific immunodetection of human glandular kallikrein 2 in serum.
Becker C; Piironen T; Kiviniemi J; Lilja H; Pettersson K
Clin Chem; 2000 Feb; 46(2):198-206. PubMed ID: 10657376
[TBL] [Abstract][Full Text] [Related]
19. Identification of human glandular kallikrein hK2 from LNCaP cells.
Grauer LS; Charlesworth MC; Saedi MS; Finlay JA; Liu RS; Kuus-Reichel K; Young CY; Tindall DJ
J Androl; 1996; 17(4):353-9. PubMed ID: 8889697
[TBL] [Abstract][Full Text] [Related]
20. Relative affinity and specificity of monoclonal antibodies against prostate-specific antigen.
Jette DC; Kreutz FT; Suresh MR
Tumour Biol; 1999; 20 Suppl 1():24-7. PubMed ID: 10628405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]